文献速递烧伤创面修复

Xeroform粘贴敷料:儿童部分厚度烧伤的一种新型治疗方法

Xeroform Stick-Down Dressing: A Novel Treatment for Pediatric Partial-Thickness Burns.
PubMed 文献 · Ann Plast Surg · 2024-01-24

本研究回顾性比较了111例儿童部分厚度烧伤患者,其中74例使用每日磺胺嘧啶银敷料,37例使用Xeroform粘贴敷料(2:1倾向评分匹配)。两组住院率、麻醉药用量、再上皮化时间和愈合并发症无显著差异,但Xeroform组换药次数显著减少(中位数0.5次 vs 12次,P<0.0001),住院时间有缩短趋势但无统计学意义。结论认为Xeroform粘贴敷料临床结局与标准磺胺嘧啶银敷料相当,主要优势为减少换药频率、减轻患者痛苦和简化临床护理。

要点

  • Xeroform粘贴敷料组换药次数中位数0.5次,显著少于磺胺嘧啶银组的12次(P<0.0001)。
  • 两组再上皮化时间中位数分别为13.0天(磺胺嘧啶银)和12.0天(Xeroform),无显著差异(P=0.20)。
  • 两组伤口愈合并发症发生率分别为12.5%(磺胺嘧啶银)和2.7%(Xeroform),无显著差异(P=0.15)。

核心结论

  • Xeroform粘贴敷料治疗儿童部分厚度烧伤的临床结局与标准磺胺嘧啶银敷料相当,主要优势为减少换药频率、减轻患者痛苦和简化临床护理。

研究设计与样本

  • 回顾性队列研究,纳入4年间在一家一级儿童创伤中心治疗的111例18岁以下部分厚度烧伤患儿,其中74例接受每日磺胺嘧啶银敷料治疗,37例接受Xeroform粘贴敷料治疗,采用2:1倾向评分匹配。

主要发现

  • 两组人口学特征和烧伤特征相似。
  • 两组住院率相似(磺胺嘧啶银组31.1%,Xeroform组32.4%),住院最常见原因为疼痛控制(磺胺嘧啶银组54.5%,Xeroform组58.3%),平均每日麻醉药用量相似(磺胺嘧啶银组7.7 ± 12.1 吗啡毫当量,Xeroform组5.1 ± 9.5 吗啡毫当量;P = 0.91)。
  • Xeroform组住院时间有缩短趋势但无统计学差异(中位数1天 vs 2天)。
  • Xeroform组换药次数显著减少(中位数0.5次 vs 12次;P < 0.0001)。
  • 两组烧伤再上皮化时间无差异(中位数磺胺嘧啶银组13.0天,Xeroform组12.0天;P = 0.20),伤口愈合并发症无差异(磺胺嘧啶银组12.5%,Xeroform组2.7%;P = 0.15)。

关键数值与推荐

  • Xeroform粘贴敷料由单次涂抹杆菌肽和3%三溴苯酚铋/凡士林浸渍纱布(Xeroform)组成,敷料粘附于烧伤创面并随新上皮化皮肤形成而脱落。

临床怎么用

  • 本机构将皮肤移植供区敷料改良为「粘贴式」烧伤敷料,即单次应用杆菌肽和3%三溴苯酚铋/凡士林浸渍纱布(Xeroform),旨在以成本效益高、广泛可用的方式减少换药频率和患者不适。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Burns traditionally require frequent, painful dressing changes to minimize infection risk and promote wound healing. To improve care for our pediatric population, our institution adapted a skin graft donor site dressing into a "stick-down" burn dressing consisting of a one-time application of bacitracin and 3% bismuth tribromophenate/vaseline impregnated gauze (Xeroform) that adheres to the burn and peels off as new epithelialized skin forms. The goal of which is to minimize dressing change frequency and patient discomfort in a cost-effective, widely available manner. This study aimed to compare clinical outcomes of the stick-down versus traditional topical dressings. METHODS: A retrospective cohort study of pediatric patients (age <18 year) with partial-thickness burns treated at a level I pediatric trauma center for 4 years was conducted. One hundred eleven patients were included: 74 patients treated with daily silver sulfadiazene (Silvadene) dressings matched to 37 patients treated with the Xeroform stick-down dressing using 2:1 propensity score matching. Univariate analyses used Wilcoxon rank sum and Fisher exact tests. RESULTS: The cohorts had similar demographics and burn characteristics. Both groups had similar hospitalization rates (31.1% Silvadene, 32.4% Xeroform), most commonly for pain control (54.5% Silvadene, 58.3% Xeroform), with similar average daily narcotic usage (7.7 ± 12.1 morphine milliequivalents Silvadene, 5.1 ± 9.5 Xeroform; P = 0.91). The Xeroform cohort had a shorter but statistically similar hospital stay (median, 1 vs 2 days). In addition, the Xeroform cohort required significantly less dressing changes with a median of 0.5 changes compared with 12 for the Silvadene cohort ( P < 0.0001). There was no difference in time to burn reepithelialization (median, 13.0 days for Silvadene and 12.0 days for Xeroform; P = 0.20) or wound healing complications (12.5% Silvadene, 2.7% Xeroform; P = 0.15). CONCLUSIONS: The Xeroform stick-down dressing has equivalent clinical outcomes to that of standard Silvadene dressings for the treatment of pediatric partial-thickness burns with the major advantages of decreasing dressing change frequency, minimizing patient distress and pain, and streamlining clinical care.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Grauberger JN, Joshi N, Joo A, et al. Xeroform Stick-Down Dressing: A Novel Treatment for Pediatric Partial-Thickness Burns. Ann Plast Surg. 2024. PMID: 38319984. doi:10.1097/SAP.0000000000003795

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。